EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD. – Trademark Portfolio
Entity Type: 99
EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include AKIN, EAPIN, and WAFOO.
101, Block 52, No. 67, Banggang Road,
Dongfang Community, Songgang Bao'an District, Shenzhen
Showing of trademarks Trademarks
Trademark Classifications
EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD. have?
EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD. file in?
EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 34 (Smokers Articles), Class 35 (Advertising & Business), Class 10 (Medical Apparatus). Class 34 covers tobacco; smokers articles; matches.
What are EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD.'s most well-known trademarks?
EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD.'s registered trademark portfolio includes well-known marks such as AKIN, EAPIN, and WAFOO. These are among 4 currently registered trademarks in the portfolio.
What is EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD.'s trademark registration success rate?
EAPIN VAPING TECHNOLOGY (SHENZHEN) CO., LTD. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.